R. Michael Carruthers

Insider Reports History

Location
3122 Sterling Circle, Suite 200, Boulder, CO
Signature
/s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Michael Carruthers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Chief Financial Officer Common Stock 86.2K $1.15M $13.39 Aug 12, 2025 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 26.9K $437K $18.91 Aug 12, 2025 Direct
Reneo Pharmaceuticals, Inc. Director Class A Common Stock 4.94K $13.2K $2.67 Oct 4, 2024 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 161K Aug 12, 2025 Direct
OnKure Therapeutics, Inc. Director Stock Option (right to buy) 7.65K May 28, 2025 Direct
Elevation Oncology, Inc. Director Stock Option (Right to Buy) 0 Jul 23, 2025 Direct

Insider Reports Filed by R. Michael Carruthers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EWTX Edgewise Therapeutics, Inc. Aug 12, 2025 5 -$19.1K 4 Aug 14, 2025 Chief Financial Officer
ELEV Elevation Oncology, Inc. Jul 23, 2025 5 $0 4 Jul 24, 2025 Director
ELEV Elevation Oncology, Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
OKUR OnKure Therapeutics, Inc. May 28, 2025 1 $0 4 May 30, 2025 Director
EWTX Edgewise Therapeutics, Inc. May 1, 2025 3 -$21.6K 4 May 7, 2025 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Oct 11, 2024 2 $49.7K 4 Oct 16, 2024 Chief Financial Officer
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 5 $0 4 Oct 8, 2024 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Director
EWTX Edgewise Therapeutics, Inc. Sep 20, 2024 7 -$3.39M 4 Sep 24, 2024 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Aug 12, 2024 2 $0 4 Aug 14, 2024 Chief Financial Officer
ELEV Elevation Oncology, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
EWTX Edgewise Therapeutics, Inc. May 1, 2024 3 -$40.8K 4 May 3, 2024 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Jan 23, 2024 3 -$1.25M 4 Jan 25, 2024 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Aug 17, 2023 1 $0 4 Aug 18, 2023 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Jun 22, 2023 2 $7.1K 4 Jun 26, 2023 Chief Financial Officer
ELEV Elevation Oncology, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
EWTX Edgewise Therapeutics, Inc. May 1, 2023 3 -$11.9K 4 May 3, 2023 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Aug 8, 2022 1 $0 4 Aug 10, 2022 Chief Financial Officer
ELEV Elevation Oncology, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
EWTX Edgewise Therapeutics, Inc. May 23, 2022 2 $0 4 May 25, 2022 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. May 1, 2022 1 $0 4 May 3, 2022 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 19, 2021 Chief Financial Officer
ELEV Elevation Oncology, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director